We measured the activities of two mitochondrial enzymes, the mitochondrial form of aspartate aminotransferase (EC 2.6.1.1) and glutamatedehydrogenase (EC 1.4.1.2), in the serum of apparentlyhealthy persons (n = 84) and patients suffering from chronicliver diseases(n = 43). The distribution of activities for glutamate dehydrogenase, but not mitochondrial aspartate aminotransferase, was sex-dependent. The upper limits of the reference intervals (99thpercentile) at 37#{176}C were 3.2 U/L for mitochondrial aspartate aminotransferase, 6.4 U/L forglutamatedehydrogenase (women), and 11.0 U/L forglutamatedehydrogenase (men);therewas a weak correlation between the activities ofboth mitochondrial enzymes (r = 0.439). In patients with chronic liver diseases we found a greaterincrease in the activity of glutamate dehydrogenase than of mitochondrial aspartate aminotransferase and the correlation between the two mitochondrial enzymes was stronger. The diagnostic sensitivity and specificity of either mitochondrial enzyme was less than that of total aspartate aminotransferase, alanine aminotransferase (EC 2.6.1.2), or y-glutamyltransferase (EC 2.3.2.2). 
For the activity determinationsof A5pAT, A1aAT, and G1DH, we incubatedtheserum samples intheirappropriate reaction mixturescontaining all components except2-oxoglutarate;after 7 mm we initiated thereaction by adding 2-oxoglutarate. For y-GT and ALP activity determinations we started the reactions by adding the serum specimensto the reagents 1 win beforemeasuring the activity. To determine m-AspAT activity, we incubatedserum samples with anti-s- 
Results
G1DH and m-AspAT activity and the m-AspAT/t-AspAT ratio were normallydistributed (p<0.05)forthe 84 normal individuals, although G1DH activity and m-AspAT/t-AspAT differed between men and women (Tables2 and 3).mAspAT did not show thisphenomenon (1.66 ± 0.66U/L for women; 1.66 ± 0.70 U/L formen, mean ± SD). Reference intervals based on thesenormal distributions and nonparametric calculation are given in Tables 2 and 3 . In general, the values calculated by these two statistical procedures agreewell.
Of specialinterest is the relationship between the two mitochondrialenzyme activities in human serum. This relationship was characterized in the controlgroup by the equation G1DH = 1.56 AspAT + 1.31 (r 0.439).The patientgroup,on the otherhand, had a greaterincreaseof G1DH activities than AspAT activities but a bettercoefficient ofcorrelation: G1DH = 4.77 AspAT + 1.46(r = 0.794). For patients with m-AspAT activities <3.8 U/L the relation- AspAT antibodies and determined the activity as described previously (5) 
AspAT activity.
Results (U) are expressed as mol . min'. We used the followingreferenceintervals (7, 9, 10), given as the 99th percentile (and the 90th percentile in parentheses):
A1aAT, 34(24) U/L forwomen, 49(34)U/L formen; total-AspAT, 34 (26)UIL for women, 35 (29) U/L for men; y-GT, 40 (25) U/L for women, 60 (35) U/L for men; ALP, 220 (170) U/L for women, 295 (225) U/L for men. These reference intervals were calculated from activity determinations for200 (fory-GT, ALP) and about 1000 (forAspAT, A1aAT) healthy persons (9).
In thisstudy,the controlgroup (n = 84; 36 women, 48 The combined data formen and women are given in Table 4 , plusthe activity valuesoftotalAspAT, A1aAT, y-GT,and ALP. Interestingly, the activities ofthe enzymes, including thetwo mitochondrial enzymes,aregreaterinpatients than inhealthypersons(p<0.001 top <0.05),whereas the ratio m-AspAT/t-AspAT isdecreasedin patients. Along with otherenzymes commonly determined in the assessment of liverdiseases, we calculated the diagnostic sensitivity and specificity of the m..AspAT activityand G1DH activity, using both the 90th and 99th percentile; because the ratiom-AspAT/t-AspAT was decreased, we calculated this ratio for the 1st and 10th percentiles ( Table   4 ). The sensitivity and specificity of the two mitochondrial enzymes forliver diseaseare less than those of total AspAT, A1aAT, and y-GT.Subdividingpatients intospecific diagnosisgroups (Table1) did not change thisfinding. Receiveroperatorcharacteristic curves for parameters involving mitochondrial enzymes are shown in Figure 1 Table 1 . Correspondenceanalysisalsoprovides important information regarding the laboratory tests used. A relatively close projection of two analytesindicates that they supply similar or redundant information. Figure 2 supports our observation that the two mitochondrialenzymes provide similar but not identical diagnostic information, and that this information is related to that obtained from measurements of t-AspAT and A1aAT activity.
Discussion
Measurements of enzyme activities in serum are useful fordiagnostic assessmentofhepatobiliary diseases. Both the amount and pattern of enzyme activities give valuable information regardingthe type,extent, and severity ofliver diseases. Increasedactivities of mitochondrialenzymes in serum have been considered to indicate more severeinjury ofthe liver (1) . Although severalreports have relatedthe activities ofm-AspAT (6,15, 16) and G1DH (17) (18) (19) (20) (21) (22) methods (3, 20, 23) or results presented in abstracts (24), which are insufficient for comparing the diagnostic significance of these two mitochondrial enzymes.
For both mitochondrialenzymes, we found a gaussian distribution of activities in the controlgroup. The "liver integrity"
ofthepersons in this control group-an important point, because the form ofthe distribution can be influenced by improper selection of the control group (25)-was further characterized by determinations of A1aAT, total AspAT, y-GT, and ALP activities. Graubaum et al. (26) alsodescribed a normal distribution of m-AspAT activity. Moreover, in a study with a smaller group about 10 years ago we observed a tendencytowards a log-normal distribution of G1DH (27) . However, we had not determined y-GT activities in that group,so we couldnot definitively excludepersonswith a possible liverimpairment (particularly alcoholics) from the control group as we have in the presentstudy.
With respecttoreference intervals form-AspAT activity, resultsfrom our study cannot be directly compared with those of others because of the different techniques for determiningtotal enzyme activity as wellas forseparating the isoenzymes.
The ratioof m-AspAT/t-AspAT should, however, be reasonably comparable among studies.Although Schmidt et al. found that more than 30% of serum AspAT activity ismAspAT; severalinvestigators have reportedintermediate values(6,16, 29-31). We determined that,at most,about 10% of the total AspAT in normal individualsis the mitochondrialenzyme, in agreement with severalother authors(29-31).
One sourceofthesedifferent findings may be variation in the use ofpyridoxal phosphate.We measured AspAT activity by theG.D.R.standardized procedure for routinediagnosticmeasurement, in which exogenouscofactor isnot added. Adding this cofactor(about 100 pmolIL) to the reaction mixture stimulates total AspAT activity by about 40% (32, 33). Kamei etal.(6)reportthatthe activity ofm-AspAT is enhanced more by pyridoxalphosphate than isthat of sAspAT, an effect thatwould suggestwe have underestimated the activity ofthe mitochondrial enzyme. However, the degreeofunderestimation, ifany,islow and thepercentage ofm-AspAT innormal individuals isessentially thesame as thatreported earlier fora less-well-defined population, but determined with an assay includingexogenous pyridoxal phosphate (34). We concludethat reports of substantially different proportions ofm-AspAT in normal human serum are based on eithermethods of insufficient sensitivity or thosethat overestimatethis fraction, perhaps through incomplete immunoprecipitationor errors associatedwith chromatographicseparation (4) .
Over the pastdecade,G1DH activity has been determined with activator-optimized methods (8, 35, 36) .
The addition of the activators, ADP and (or)leucine, can doublethe G1DH activity measured intheirabsence. Ellis The relationship of the activities of the two mitochondrial enzymes, m-AspAT and G1DH, has been of special interest in our investigation. Comparison of both enzyme activities in healthy persons demonstrates a statistically significant (p <0.01) but weak (r = 0.439)correlation. This is also true for patients with m-AspAT activities as high as 3.8 U!L, whereas patients with higher m-AspAT activities have a better correlation between m-AspAT and GLDH activities and a different equation for the regression line between these two enzymes. Therefore, the relationship between mAspAT and G1DH isnotconstantbut variesaccordingtothe amount of enzyme activity and is apparently related to the severity of disease. This effect could be caused by differences in the release of m-AspAT and G1DH and their elimination from the bloodstream (20). Also, for AspAT, the rate of disappearance of enzyme activity from serum may depend on the amount of activity (38).
The comparison of the activities of AIaAT, t-AspAT, y-GT, and ALP with those of m-AspAT and G1DH confirms the relatively poor diagnostic power of both m-AspAT and G1DH in detecting liver diseases (17, 21). Not only the diagnostic sensitivities but also the diagnostic specificities for both mitochondrial enzymes. are lower than for the corresponding data from the other enzymes, although G1DH activity gives slightly better results than m-AspAT or m-AspAT/t-AspAT.
A decrease of m-AspAT/t-AspAT demonstrates that sAspAT activity is preferentially increased in patients suffering from chronic liver diseases. Therefore, t-AspAT activity is more sensitivethan m-AspAT also in chronic liver diseases, because s-AspAT is the main component in human serum. However, determinations of the activity of mitochondrial enzymes could contribute to more differentiated diagnoses in liver diseases. Because of the uneven distribution of enzymes in the liver, one may thus be able to evaluate not only the degree but also the intralobular site of liver cell necrosis (18). This has been previously suggested for determinations of G1DH activity (18).
